One explanation for the protection could be that mucosal vaccination induces trained innate immunity, tissue-resident memory T cells (TRMs), anti-TB surface antibodies, the effector cytokine IL-17 and inducible bronchus-associated lymphoid tissue (iBALT) in the lung [11,15]. This evidence concerns the gene IL17A and tuberculosis.